Strut Anti-Aging Formula review: the facial cream within a mixed product page
Four facial ingredients and a 15 g offer are clear; neighboring eye and neck formulas cannot settle its strengths.
Public-source editorial review. No clinician sign-off, firsthand testing, patient-image assessment or individual prescription advice claimed.
Strut’s Anti-Aging Formula is presented as a prescription cream with four named ingredients and a $49 price for 15 g. That sounds like a compact product description. Reading farther, however, brings in eye and neck cream panels with different ingredients. The central question is which details actually belong to the facial formula being reviewed.
The repeated facial heading and ingredient FAQ provide a useful anchor. The terms explain another part of the offer: clinical services come through Titan Medical Group, while Strut provides the platform. Keeping the formula, neighboring products and clinical arrangement distinct makes this offer easier to understand without guessing missing facial strengths or results.
Within this reading
Four ingredients define the facial offer
The Anti-Aging Formula heading identifies tretinoin, niacinamide, lactic acid and sodium hyaluronate in a prescription dermatology cream. The product is advertised at $49 for 15 g. Its ingredient and safety sections repeat that four-ingredient description, giving the assigned cream a recognizable identity despite other product material appearing farther down the page.
This is a compounded prescription offer, rather than a standardized retail moisturizer. Its published ingredients do not establish numeric facial strengths or a complete inactive base. Our Musely review and Skin Medicinals review provide separate product readings for comparison. Neither can fill gaps in the actual composition of the Strut cream.
The eye and neck panels describe different products
A later eye-cream panel describes a seven-ingredient preparation including tacrolimus and a separately stated tretinoin strength. Another neck-cream panel names a six-ingredient formula including DMAE. Those panels are labeled for different areas and have different ingredient combinations. They are not a full quantitative declaration for the four-ingredient facial formula.
This matters because importing their strengths would make the facial review look more specific than its own information supports. The repeated facial FAQ names the four ingredients without settling their concentrations. The options comparison keeps such disclosure gaps visible. A neighboring product’s detailed list is useful evidence of a difference, rather than permission to merge two preparations.
The claimed benefits are broader than a disclosed test
The facial explanation discusses the appearance of fine lines and dark spots, hydration and elasticity. It describes roles for the named ingredients. These are Strut’s product and ingredient claims. The product explanation does not provide a participant group, control or complete finished-facial-formula study that would quantify those benefits for the assigned cream.
The AAD wrinkle guidance separately explains that moisture can change the appearance of some fine lines. That general context is helpful, but it does not confirm how much this combination moisturizes or changes wrinkles. Our fine versus deep wrinkles guide also keeps a softer-looking surface distinct from removal of a deeper crease or reversal of skin aging.
Titan Medical Group is the named clinical practice
The Strut terms identify Titan Medical Group as the clinical service provider. They state that Strut does not itself provide medical care and that providers are independently employed or contracted through the medical group. This explains how the company’s online platform differs from the professional practice making a prescribing decision.
The prescription provisions say a prescription is not guaranteed, and availability is limited to U.S. states where the services operate. Those are meaningful qualifications to the convenient online presentation. We have not assessed a clinician, submitted a consultation or checked a dispensed package. The public arrangement identifies responsibility; it does not establish personal eligibility, care quality or an observed response to a medical question.
The $49 figure sits within a subscription arrangement
The product FAQ generally describes online visits as complimentary, with payment for a prescription if the person qualifies. It also states a $40 physician consultation charge for transferring a prescription outside the preferred pharmacy network. That condition matters alongside the $49 product headline; the lowest advertised amount is not the total for every possible arrangement.
The terms describe recurring prescription charges on 30- or 90-day refill schedules until paused or cancelled. These are billing descriptions, not a suggested application calendar. The records do not establish a tested cancellation, an actual transfer or a final individual bill. Keeping the subscription and pharmacy condition attached to the price makes the commercial comparison more useful.
A comfort description is not a tolerance guarantee
The facial FAQ describes a hypoallergenic dermatological base while also listing possible itching, redness, scaling, dryness, peeling and other reactions. Those statements need to be read together. The favorable base description does not mean every person will find the cream comfortable, and the warning list does not measure how often reactions occur with this exact formulation.
The missing full inactive list also limits a more detailed product comparison. We cannot assign ingredient concentrations from the eye or neck preparations, or treat a reaction as evidence that the facial cream is improving wrinkles. The RENOVA label guide explains why an exact preparation matters when reading both benefits and limitations. Its findings concern that separate product, not Strut’s customized mixture.
The compounded disclosure is the clearest boundary
Strut’s disclosure says its compounded medication is not FDA-approved and has not been evaluated by FDA for safety, effectiveness or quality. The FDA explanation describes that regulatory category. A familiar active ingredient, physician involvement or an ingredient discussion cannot provide approval of the finished blend in place of that missing review.
The offer still has useful specifics: four repeatedly named facial ingredients, a quantity, a headline price and a named clinical practice in the terms. Its weakest point is the confusion created by neighboring formulas. A complete facial declaration and matched product evidence would improve the comparison. Until then, the documented four-ingredient identity should remain narrower than the page’s combined eye, neck and facial material.
The records behind this article
- Strut Anti-Aging Formula ↗Official compounded prescription page; facial identity and FAQ with interleaved eye/neck blocks · Accessed 2026-10-01
- AAD: Wrinkle remedies ↗Professional society public guidance; moisturizer appearance effects and treatment expectations · Accessed 2026-10-01
- Strut Health Terms and Conditions ↗Official terms; Titan Medical Group role, availability and subscription provisions · Accessed 2026-10-01
- FDA: Compounding and the FDA, questions and answers ↗Federal regulator consumer explanation · Accessed 2026-10-01